IceCure Medical Ltd (ICCM)
USD 1.23
(-0.81%)
USD 1.23
(-0.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.57 Million USD | 6.95% |
| 2022 | -16.73 Million USD | -72.14% |
| 2021 | -9.72 Million USD | -122.94% |
| 2020 | -4.36 Million ILS | 5.36% |
| 2019 | -4.6 Million ILS | -45.37% |
| 2018 | -3.17 Million ILS | -18.97% |
| 2017 | -2.66 Million ILS | 14.13% |
| 2016 | -3.1 Million ILS | 12.06% |
| 2015 | -3.52 Million ILS | 13.83% |
| 2014 | -4.09 Million ILS | -9.15% |
| 2013 | -3.75 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.61 Million USD | -0.63% |
| 2024 Q2 | -3.18 Million USD | 10.76% |
| 2023 Q3 | -4.12 Million USD | -1.03% |
| 2023 FY | -15.57 Million USD | 6.95% |
| 2023 Q1 | -3.95 Million USD | -0.64% |
| 2023 Q2 | -4.08 Million USD | -3.13% |
| 2023 Q4 | -3.59 Million USD | 12.81% |
| 2022 Q2 | -4.28 Million USD | 3.25% |
| 2022 FY | -16.73 Million USD | -72.14% |
| 2022 Q4 | -3.93 Million USD | 4.12% |
| 2022 Q1 | -4.42 Million USD | -41.46% |
| 2022 Q3 | -4.1 Million USD | 4.2% |
| 2021 Q4 | -3.12 Million USD | -9.75% |
| 2021 Q2 | -2.55 Million USD | -114.0% |
| 2021 Q1 | -1.19 Million USD | -1.02% |
| 2021 FY | -9.72 Million USD | -122.94% |
| 2021 Q3 | -2.85 Million USD | -11.63% |
| 2020 FY | -4.36 Million ILS | 5.36% |
| 2020 Q4 | -1.18 Million USD | 12.0% |
| 2020 Q2 | -809.5 Thousand USD | 0.0% |
| 2020 Q1 | -809.5 Thousand USD | 25.84% |
| 2020 Q3 | -1.34 Million USD | -65.78% |
| 2019 Q3 | -1.08 Million USD | 8.08% |
| 2019 Q4 | -1.09 Million USD | -0.66% |
| 2019 FY | -4.6 Million ILS | -45.37% |
| 2019 Q2 | -1.17 Million USD | -1.79% |
| 2019 Q1 | -1.15 Million USD | -27.06% |
| 2018 Q1 | -801.2 Thousand USD | -23.52% |
| 2018 FY | -3.17 Million ILS | -18.97% |
| 2018 Q4 | -912.12 Thousand USD | -13.08% |
| 2018 Q3 | -806.62 Thousand USD | -5.48% |
| 2018 Q2 | -764.69 Thousand USD | 4.56% |
| 2017 Q3 | -693.57 Thousand USD | -6.28% |
| 2017 FY | -2.66 Million ILS | 14.13% |
| 2017 Q4 | -648.63 Thousand USD | 6.48% |
| 2017 Q1 | -628.53 Thousand USD | 12.0% |
| 2017 Q2 | -652.61 Thousand USD | -3.83% |
| 2016 Q4 | -714.27 Thousand USD | -31.83% |
| 2016 Q1 | -1.1 Million USD | -64.16% |
| 2016 Q2 | -781.59 Thousand USD | 29.13% |
| 2016 Q3 | -541.82 Thousand USD | 30.68% |
| 2016 FY | -3.1 Million ILS | 12.06% |
| 2015 Q3 | -938.11 Thousand USD | -1.64% |
| 2015 Q4 | -671.79 Thousand USD | 28.39% |
| 2015 Q2 | -923.01 Thousand USD | 8.19% |
| 2015 Q1 | -1 Million USD | -15.01% |
| 2015 FY | -3.52 Million ILS | 13.83% |
| 2014 Q3 | -1.14 Million USD | 4.76% |
| 2014 FY | -4.09 Million ILS | -9.15% |
| 2014 Q1 | -1.21 Million USD | -15.37% |
| 2014 Q2 | -1.19 Million USD | 1.15% |
| 2014 Q4 | -874.16 Thousand USD | 23.39% |
| 2013 Q4 | -1.05 Million USD | -35.46% |
| 2013 Q1 | -945.34 Thousand USD | 17.44% |
| 2013 FY | -3.75 Million ILS | 0.0% |
| 2013 Q2 | -891.65 Thousand USD | 5.68% |
| 2013 Q3 | -775.55 Thousand USD | 13.02% |
| 2012 Q4 | -1.14 Million USD | 1.6% |
| 2012 Q3 | -1.16 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -8.46% |
| Cerus Corporation | -30.05 Million USD | 48.172% |
| OrthoPediatrics Corp. | -25.76 Million USD | 39.548% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -46.648% |
| Talis Biomedical Corporation | -66.81 Million USD | 76.688% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 9.944% |
| Inogen, Inc. | -109.38 Million USD | 85.761% |
| Spectral AI, Inc. | -12.98 Million USD | -19.963% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 75.114% |
| CVRx, Inc. | -43.1 Million USD | 63.863% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -341.497% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -25.33% |
| Orthofix Medical Inc. | -139.11 Million USD | 88.803% |
| Venus Concept Inc. | -28.3 Million USD | 44.979% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 71.171% |
| Bioventus Inc. | -81.72 Million USD | 80.941% |
| BrainsWay Ltd. | -4.92 Million USD | -216.136% |
| Envoy Medical, Inc. | -18.37 Million USD | 15.214% |
| electroCore, Inc. | -18.8 Million USD | 17.171% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 67.873% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 9.799% |
| MaxCyte, Inc. | -48.29 Million USD | 67.751% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -30.286% |
| Nexalin Technology, Inc. | -5.69 Million USD | -173.441% |
| PAVmed Inc | -68.79 Million USD | 77.359% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 72.463% |
| RxSight, Inc. | -50.08 Million USD | 68.901% |
| Sight Sciences, Inc. | -57.27 Million USD | 72.804% |
| SI-BONE, Inc. | -46.93 Million USD | 66.811% |
| TELA Bio, Inc. | -44.07 Million USD | 64.66% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 71.235% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 69.713% |
| LivaNova PLC | -68.49 Million USD | 77.261% |
| 908 Devices Inc. | -42.75 Million USD | 63.572% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 91.017% |
| Nemaura Medical Inc. | -9.59 Million USD | -62.331% |
| NeuroPace, Inc. | -27.17 Million USD | 42.681% |
| LENSAR, Inc. | -12.22 Million USD | -27.369% |
| Apyx Medical Corporation | -17.25 Million USD | 9.751% |
| Cutera, Inc. | -156.23 Million USD | 90.03% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -81.032% |
| BioSig Technologies, Inc. | -28.51 Million USD | 45.37% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 82.227% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 30.607% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 113.966% |
| Axonics, Inc. | -26.05 Million USD | 40.223% |
| Outset Medical, Inc. | -169.77 Million USD | 90.825% |
| IRIDEX Corporation | -10 Million USD | -55.651% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 85.732% |
| IRadimed Corporation | 20.03 Million USD | 177.742% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -88.915% |
| INVO Bioscience, Inc. | -6.76 Million USD | -130.171% |
| Telesis Bio, Inc. | -35.15 Million USD | 55.687% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 208.695% |
| Varex Imaging Corporation | 32.1 Million USD | 148.523% |
| Quipt Home Medical Corp. | 3.91 Million USD | 497.448% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -28.377% |
| Pulmonx Corporation | -61.93 Million USD | 74.851% |
| Dynatronics Corporation | -2.27 Million USD | -585.247% |
| Modular Medical, Inc. | -17.52 Million USD | 11.142% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -6.401% |
| Semler Scientific, Inc. | 22.25 Million USD | 169.986% |
| InMode Ltd. | 195.66 Million USD | 107.961% |
| Bruker Corporation | 436.9 Million USD | 103.565% |
| Cytosorbents Corporation | -31.2 Million USD | 50.092% |
| DexCom, Inc. | 597.7 Million USD | 102.606% |
| Align Technology, Inc. | 643.33 Million USD | 102.421% |
| Viveve Medical, Inc. | -21.55 Million USD | 27.732% |
| ZimVie Inc. | -30.93 Million USD | 49.656% |
| Movano Inc. | -29.69 Million USD | 47.538% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 44.062% |
| Nexalin Technology, Inc. | -5.69 Million USD | -173.441% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -341.497% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 93.322% |
| Profound Medical Corp. | -28.61 Million USD | 45.569% |
| Insulet Corporation | 220 Million USD | 107.08% |
| enVVeno Medical Corporation | -25.23 Million USD | 38.284% |
| Surmodics, Inc. | -5.64 Million USD | -175.926% |
| iCAD, Inc. | -7.68 Million USD | -102.575% |
| Nuwellis, Inc. | -17.63 Million USD | 11.651% |
| Biotricity, Inc. | -8.82 Million USD | -76.433% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 87.555% |
| Aethlon Medical, Inc. | -12.63 Million USD | -23.261% |
| InspireMD, Inc. | -21.14 Million USD | 26.33% |
| PAVmed Inc. | -68.79 Million USD | 77.359% |
| BIOLASE, Inc. | -17.93 Million USD | 13.163% |
| Beyond Air, Inc. | -63 Million USD | 75.279% |
| FONAR Corporation | 16.53 Million USD | 194.198% |
| AxoGen, Inc. | -21.46 Million USD | 27.425% |
| Vivani Medical, Inc. | -26.96 Million USD | 42.236% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 186.337% |
| Inari Medical, Inc. | -14.03 Million USD | -11.003% |
| UFP Technologies, Inc. | 57.66 Million USD | 127.012% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -216.097% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -147.012% |
| Tenon Medical, Inc. | -15.72 Million USD | 0.96% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -108.402% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 63.528% |
| AdaptHealth Corp. | -598.4 Million USD | 97.397% |
| Sintx Technologies, Inc. | -13.35 Million USD | -16.604% |
| NanoVibronix, Inc. | -3.43 Million USD | -353.318% |
| Quanterix Corporation | -49.7 Million USD | 68.661% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -28.377% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -3977.487% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 95.343% |
| TransMedics Group, Inc. | -28.72 Million USD | 45.779% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 34.034% |
| NeuroMetrix, Inc. | -7.15 Million USD | -117.8% |
| Hyperfine, Inc. | -48.11 Million USD | 67.628% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 76.047% |
| Biomerica, Inc. | -6.36 Million USD | -144.636% |
| Bone Biologics Corporation | -9.42 Million USD | -65.205% |
| AVITA Medical, Inc. | -40.4 Million USD | 61.448% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -51.059% |
| Silk Road Medical, Inc | -59.27 Million USD | 73.721% |